Sort by
Refine Your Search
-
(DDLS) is a 12-year initiative funded with a total of 3,1 billion SEK from the Knut and Alice Wallenberg Foundation. The purpose of the program is to recruit and train the next generation of researchers
-
/organizations, but brought together under the DDLS program, which has four strategic areas: cell and molecular biology, evolution and biodiversity, precision medicine and diagnostics, epidemiology and biology of
-
structures and cellular processes to human health and global ecosystems. The SciLifeLab and Wallenberg National Program for Data-Driven Life Science (DDLS), coordinated by SciLifeLab, aims to recruit and train
-
and supervise students within relevant educational programmes at Linköping University. The work can include administrative tasks such as course development, being course coordinator or examiner. You
-
granted in exceptional circumstances). The position as Assistant Professor is a time limited career development position for a maximum of six years in total at KI. The KI SciLifeLab SFO Program provides
-
track record, including high-impact and highly cited publications. Good knowledge in English, oral and written. Additional merits Expertise in web programming and web application development. Expertise in
-
DNA unit, you are part of a team that includes staff at Stockholm University, and is part of a research environment that includes the Human Evolution research program at Uppsala University and the
-
computer science or an equivalent education, such as a Master of Science in Engineering. A minimum of 10 years of documented experience working in IT as a developer, systems specialist, architect, or similar role
-
Cell initiative is a new flagship research program aiming to develop an AI model of a human cell to predict key cellular functions. It is funded by the Knut & Alice Wallenberg Foundation (KAW) and
-
on developing strategies for personalized prevention, individualized risk prediction, early detection, and tailored therapeutic and prognostic tools for pancreatic cancer. The team currently includes